Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2015 - 2025)
Emergent BioSolutions (EBS) posted Liabilities from Discontinued Operations of $4.5 million for Q3 2025, down 4.26% on a QoQ basis from $4.7 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2015 - 2025) Analysis & Trends
Emergent BioSolutions has reported Liabilities from Discontinued Operations for 4 years, with the latest figure at $4.5 million in Q3 2025.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $4.5 million in Q3 2025; TTM through Sep 2025 was $4.5 million, a N/A change from a year earlier, with the FY2015 full-year figure at $17.3 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations was $4.5 million for Q3 2025 at Emergent BioSolutions, down from $4.7 million in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was $37.5 million in Q1 2023, with the low at $4.5 million in Q3 2025.
- Average Liabilities from Discontinued Operations over 3 years is $12.3 million, with a median of $4.8 million recorded in 2025.
- The largest YoY upside for Liabilities from Discontinued Operations was 53.47% in 2025 against a maximum downside of 53.47% in 2025.
- Over 3 years, Liabilities from Discontinued Operations stood at $37.5 million in 2023, then plunged by 73.07% to $10.1 million in 2024, then slumped by 55.45% to $4.5 million in 2025.
- The last three Liabilities from Discontinued Operations figures came in at $4.5 million (Q3 2025), $4.7 million (Q2 2025), and $4.8 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Jun 30, 2024 | 10.10 Mn |
| Mar 31, 2023 | 37.50 Mn |
| Dec 31, 2015 | 17.35 Mn |
API Access
Emergent BioSolutions Liabilities from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-from-discontinued-operations", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();